Clinical Trial Update: Effect of Oral N-Acetyl Cysteine in Prevention of Necrotizing Enterocolitis in Preterm Neonates With Feeding Intolerance [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating oral N-acetylcysteine for prevention of necrotizing enterocolitis in preterm neonates with feeding intolerance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Necrotizing Enterocolitis
• Preterm Birth Complications

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Ain Shams University | Conditions: Preterm Neonates and Feeding Intolerance, Necrotizing Enterocolitis | Phase 4 | Status: UNKNOWN